Changes in coding of pneumonia and impact on the Hospital Readmission Reduction Program
Related Experiment Video
Updated: Jan 5, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Jason D Buxbaum1, Peter K Lindenauer2, Colin R Cooke3
1PhD Program in Health Policy, Graduate School of Arts and Sciences, Harvard University, Cambridge, Massachusetts.
Objective:
To evaluate whether changes in diagnosis assignment explain reductions in 30-day readmission for patients with pneumonia following the Hospital Readmission Reduction Program (HRRP).
Data Sources:
100 percent MedPAR, 2008-2015.
Study Design:
Retrospective cohort study of Medicare discharges in HRRP-eligible hospitals. Outcomes were 30-day readmission rates for pneumonia under a "narrow" definition (used for the HRRP until October 2015; n = 2 288 644) and a "broad" definition that included certain diagnoses of sepsis and aspiration pneumonia (used since October 2015; n = 3 618 215). We estimated changes in 30-day readmissions in the pre-HRRP period (January 2008-March 2010), the HRRP implementation period (April 2010-September 2012), and the HRRP penalty period (October 2012-June 2015).
Principal Findings:
Under the narrow definition, adjusted annual readmission rates changed by +0.07 percentage points (pp) during the pre-HRRP period (95% CI: -0.03 pp, +0.18 pp), -1.07 pp during HRRP implementation (95% CI: -1.15 pp, -0.99 pp), and -0.09 pp during the penalty period (95% CI: -0.18 pp, -0.00 pp). Under the broad definition, 30-day readmissions changed by +0.21 pp during the pre-HRRP period (95% CI: +0.12 pp, +0.30 pp), -1.28 pp during HRRP implementation (95% CI: -1.35 pp, -1.21 pp), and -0.09 pp during the penalty period (95% CI: -0.16 pp, -0.02 pp).
Conclusions:
Changes in the coding of inpatient pneumonia admissions do not explain readmission reduction following the HRRP.
Insights
Reductions in 30-day pneumonia readmissions after the Hospital Readmission Reduction Program (HRRP) are not explained by changes in diagnosis coding. This study found no evidence that altered pneumonia admission diagnoses account for the observed decreases in readmission rates.
Area of Science:
- Health Services Research
- Healthcare Policy
- Pulmonary Medicine
Background:
- The Hospital Readmission Reduction Program (HRRP) aimed to reduce 30-day hospital readmissions for conditions including pneumonia.
- Concerns have been raised that changes in diagnosis coding practices might artificially inflate reductions in readmission rates.
Purpose of the Study:
- To investigate whether shifts in diagnosis assignment explain the observed decreases in 30-day pneumonia readmissions following the implementation of the HRRP.
Main Methods:
- A retrospective cohort study analyzed Medicare data from 2008-2015 for HRRP-eligible hospitals.
- Readmission rates were compared using a "narrow" definition (pre-October 2015) and a "broad" definition (post-October 2015) including sepsis and aspiration pneumonia.
- Changes in readmissions were assessed across pre-HRRP, HRRP implementation, and HRRP penalty periods.
Main Results:
- Under the narrow definition, readmissions decreased by 1.07 pp during HRRP implementation but showed minimal change during the penalty period (-0.09 pp).
- Under the broad definition, readmissions decreased by 1.28 pp during HRRP implementation and also showed minimal change during the penalty period (-0.09 pp).
- The observed reductions in 30-day pneumonia readmissions were not attributable to changes in diagnosis coding.
Conclusions:
- Changes in the coding of inpatient pneumonia admissions do not account for the readmission reductions observed after the Hospital Readmission Reduction Program.
- The findings suggest that the decrease in readmissions is likely due to genuine improvements in care or other factors, rather than coding artifacts.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia II: Pathophysiology